jueves, 22 de agosto de 2024

The Lancet Gastroenterology & Hepatology in conversation with Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

https://thelancetgastrohep.buzzsprout.com/1728646/15460606-arndt-vogel-on-the-naliricc-trial-of-nanoliposomal-irinotecan-in-pretreated-advanced-biliary-tract-cancer?utm_campaign=update-langas&utm_medium=email&_hsenc=p2ANqtz-8IArvUc_Ojec17b5aIYI44nGuVG1BUD_lXzRz5GNqC7h4mUboCU_MGMWGX3lfyVbrG_psJC6oIL4ebeh_9b7OjARDvfA&_hsmi=320910164&utm_content=320863460&utm_source=hs_email

No hay comentarios:

Publicar un comentario